>

WEBINARS

RSS
>

MEETINGS / EVENTS

RSS
>

FDA MEDWATCH ALERTS

RSS

January 12, 2012

Respironics, Inc. Trilogy 100 Ventilators: Class I Recall - Device May Stop Delivering Therapy to Patient

Summary:

FDA notified health care professionals of the Class 1 recall of this product due to a manufacturing issue can stop delivering therapy to the patient. Part of the blower that circulates air and other gases through the ventilator may move out of position and cause the device to alarm.  Failure to respond could result in the potential for harm or death of a ventilator-dependent patient.

January 12, 2012

Bedford Laboratories Vecuronium Bromide And Polymyxin B For Injection USP For Injection: Recall - Glass Particles

Summary:

Bedford Laboratories issued guidance on the nationwide voluntary product recalls originally issued on August 2, 2011. The recalls were initiated after the discovery of a visible glass particle in a limited number of vials within the lots listed.

January 09, 2012

Endo Pharmaceuticals Opiate Products by Novartis Consumer Health: Public Health Advisory - Potential Safety Risk

Summary:

FDA is advising health care professionals and patients of a potential problem with opiate products manufactured and packaged for Endo Pharmaceuticals by Novartis Consumer Health at its Lincoln, Nebraska manufacturing site.

>

ASA FEATURED PRODUCT

Self-Education and Evaluation (SEE) Program

SKU: 30701-12CE

... Read more »

Single Copies, Member Price: $300

ASA Files a Motion to Intervene in the “Red Flags Rule”

Monday, August 23, 2010

On August 18, ASA joined 24 other medical specialty groups in filing a motion to intervene in a lawsuit originated in May by the American Medical Association (AMA), the American Osteopathic Association (AOA), and the Medical Society of the District of Columbia against the Federal Trade Commission (FTC) regarding the “Red Flags Rule.” The rule involves establishment of an identity theft prevention program by “creditors,” which the FTC defines to include most healthcare providers. While ASA is supportive of the FTC’s efforts to prevent identity theft, there is concern about future implications of classifying physicians as “creditors.” Though the lawsuit seeks to declare unlawful the “Red Flags Rule” as it applies to the members of the AMA, the AOA, and the state medical societies, through this motion to intervene, ASA seeks to extend the lawsuit to cover its member physicians. Unless the FTC delays again, enforcement begins on January 1, 2011. We will file additional legal documents reflecting our claim assuming our motion to intervene is granted.

Please see the links below for additional information on the Red Flags Rule and a copy of the motion to intervene.

« Back to Washington Alerts